Cell>Point and HYUN IMC Expand License in South Korea to Include Hanmi Pharmaceutical, Co., Ltd for Cancer and Heart Disease Imaging
Third License Completes the Company’s Initiative to Secure a Strong Pharmaceutical Partner for the South Korean Market CENTENNIAL, Colo.,…
Read
Development of 99mTc-EC-tyrosine for Early Detection of Breast Cancer Tumor Response to the Anticancer Drug Melphalan
Published: January 2013, Vol. 20, No. 1, Academic Radiology https://celltheranostics.com/wp-content/uploads/2019/11/Deveopment-of-99mTc-EC-tyrosine-for-Early-Detection-of-Breast-Cancer-Tumror-Response-to-the-Anticancer-Drug-Melphalan.pdf
Read
Cardiology Imaging Technologies presents cardiology clinical trial data on EC-G at the American Society of Nuclear Cardiology 2012 Annual Conference
CENTENNIAL, Colo., September 11, 2012 – Cell>Point announced today that Cardiovascular Imaging Technologies presented a Phase 1b clinical…
Read
Cell>Point to Present at the 26th Indian Cooperative Oncology Network (ICON) Meeting in Bengaluru, India
CENTENNIAL, Colo., March 17, 2012 – Cell>Point today that Company President David Rollo, M.D., Ph.D.,will present at the…
Read
Cell>Point Announces Agreement with the FDA on a Special Protocol Assessment for the Phase 3 Technetium-99m-EC-G Lung Cancer Imaging Trial
CENTENNIAL, Colo., March 8, 2012 – Cell>Point, L.L.C , announced today that it received a letter from the…
Read
Cell>Point Executes Asia License with HYUN IMC for Cancer and Heart Disease Diagnostic Imaging Agent, Technetium-99m-EC-G
CENTENNIAL, Colo., February 28, 2012 – Cell>Point announced today that it had entered into a licensing agreement for…
Read
CENTENNIAL, Colo., January 24, 2012—Cell>Point announced today that it has entered into a long-term collaboration agreement including product licenses for Brazil with MJM Productos Farmaceuticos e de Radioprotecao Ltda., or “Radiopharmacus.”
Cell>Point announced today that it has entered into a long-term collaboration agreement including product licenses for Brazil with…
Read
CENTENNIAL, Colo., November 23, 2011
Cell>Point announced today that the University of Texas M.D. Anderson Cancer Center will present pre-clinical results on Cell>Point’s…
Read
CENTENNIAL, Colo., June 6, 2011—Cell>Point announced today that it will present Phase 2 clinical trial results for its cancer molecular imaging agent, 99mTc-EC-G
https://www.cellpointweb.com/2011-SNM-Final.pdf
Read
CENTENNIAL, Colo., March 18, 2010—Cell>Point announced today that it was awarded March 15, 2011 the North American SPECT Radiopharmaceuticals Technology Innovation Award by Frost & Sullivan.
Read
Cell>Point adds Dr. Wayne Yakes to Board of Advisors – 11/22/2010
CENTENNIAL, Colo., November 22, 2010 – Cell>Point is pleased to announce that Dr. Wayne Yakes has joined our…
Read
Cell>Point to present at 52nd American Society of Hematology Annual Meeting December 4-7, 2010.
CENTENNIAL, Colo., December 1, 2010 – Dr. Lan V. Pham, Department of Hematophathology, The University of Texas M.D.…
Read
